Procedural· Chapter 30

Colonoscopy Practice and Quality

USPSTF age-45 screening, ADR and withdrawal-time benchmarks, the bowel-prep choice cascade (split-dose, low-volume, hyperosmolar), USMSTF post-polypectomy surveillance intervals, and the polyp resection technique decision tree from cold snare through EMR to ESD.

60 MCQs5 podcast episodes
Published by Board PearlsUpdated How we write these
  • Audio chapter
    Single-voice audio, listen on the commute.
  • ABIM-format MCQs
    5-option vignettes with full wrong-answer teaching.
  • Study guide
    Tables, decision trees, primary sources.
  • AI tutor
    Chapter-grounded, answers the question you're stuck on.

What this chapter covers

  • Section 30.1: CRC screening modalities and USPSTF age update

    Colorectal cancer screening exists because the disease has a long, recognizable precursor lesion and a survivable early stage, and the modality menu is engineered to give every patient a route in.

  • Section 30.2: Bowel preparation and procedural quality foundations

    Bowel preparation adequacy is the foundation on which every subsequent quality metric rests, because inadequate preparation roughly doubles polyp miss rates and detection technique cannot compensate for residual stool obscuring mucosa.

  • Section 30.3: Detection metrics: ADR, SSLDR, withdrawal

    Adenoma detection rate is the single most validated quality metric in colonoscopy because its association with interval cancer is robust across populations.

  • Section 30.4: Polyp recognition and morphology

    Polyp morphology drives both cancer risk assessment and resection technique selection, because morphology reflects the underlying growth pattern that determines whether a lesion has invaded vertically into the submucosa or spread horizontally along the mucosa.

  • Section 30.5: Resection technique selection

    Resection technique is selected by polyp size, morphology, and cancer-risk features.

  • Section 30.6: Malignant polyp management

    Pathology terminology in colorectal lesions is confusing and clinically consequential, and the principle that drives all malignant polyp management is that submucosal invasion, not mucosal involvement, is what carries metastatic potential.

  • Section 30.7: 2020 USMSTF post-polypectomy surveillance intervals

    The 2020 US Multi-Society Task Force update on follow-up after colonoscopy and polypectomy drives interval selection from index findings, and the principle behind interval selection is that the likelihood of metachronous advanced neoplasia within the surveillance window is calibrated to the highest-risk lesion at the index colonoscopy.

  • Section 30.8: Post-polypectomy adverse events

    Post-polypectomy adverse events are recognizable, gradable, and largely manageable when caught early, and each event has a specific anatomic or thermal mechanism that determines management.

  • Section 30.9: The serrated pathway and Lynch sorting

    The serrated pathway accounts for 15 to 30 percent of colorectal cancers and travels a molecular route distinct from the conventional adenoma-carcinoma sequence.

  • Section 30.10: Special-population colonoscopy

    Special populations modify all four phases of colonoscopy (preparation, sedation, intervention, recovery), and these modifications are best understood as patient-specific deviations from the standard algorithm rather than as separate procedures.

Podcast episodes

  1. 01

    Screening, Prep, and Detection Metrics

    Episode one of the Colonoscopy Practice and Quality chapter treats screening colonoscopy as a chain of dependencies where the weakest link governs the outcome. The organizing idea: colorectal cancer has a long precursor and a survivable early stage, so everything from the starting age to the withdrawal time exists to make prevention real rather than nominal. It walks the modality menu with the rule that any positive non-invasive test commits the patient to colonoscopy, then the split-dose preparation physiology that delivers a clean right colon. It closes on the detection metrics, adenoma detection rate as the single most validated quality measure and sessile serrated lesion detection rate as its complement on the serrated pathway.

    Read the transcript →
  2. 02

    Polyp Recognition and Resection Technique

    Episode two frames polyp management as a reading task that begins before the snare opens: has the lesion grown horizontally along the mucosa or vertically into the submucosa, because vertical growth is what carries cancer risk. Paris morphology, the NICE and JNET optical patterns, Kudo pit pattern, and the lateral spreading granularity types are all ways of reading that same growth signal, and depressed or pseudodepressed surfaces are what deep submucosal invasion looks like from above. The optical read then dictates the resection plan. Cold snare wins on safety for diminutive and small lesions, hot snare is reserved for the vascularized pedunculated stalk, EMR is standard for larger sessile and lateral spreading lesions, and en bloc resection by ESD or band-ligation is reserved for when specimen integrity is needed for staging.

    Read the transcript →
  3. 03

    The Malignant Polyp and Surveillance

    Episode three resolves the malignant polyp on one anatomic fact: lymphatics in the colon begin at the muscularis mucosae, so disease confined above it cannot metastasize while submucosal invasion opens the door to nodal spread. Intramucosal adenocarcinoma behaves as high-grade dysplasia and is cured by complete resection, which is why the word on the path report pulls toward unnecessary surgery. The Kikuchi and Haggitt systems describe depth, but the modern algorithm aggregates depth with tumor budding, differentiation, lymphovascular invasion, and margin status rather than acting on depth alone. Surveillance then calibrates the next exam to the worst lesion found, with the shortest interval winning when findings conflict and a separate six-month site check for piecemeal EMR of lesions twenty millimeters or larger.

    Read the transcript →
  4. 04

    Polypectomy Adverse Events

    Episode four teaches the post-polypectomy adverse event set through mechanism, because each event has a distinct anatomic or thermal correlate that determines the next move. Immediate bleeding is treated at the visible vessel while delayed bleeding returns for endoscopic hemostasis on the still-recognizable scar, and the prophylactic-clip decision turns on proximal location and antithrombotic risk rather than reflex. Perforation forces a closure decision driven by defect age and size, while post-polypectomy electrocoagulation syndrome mimics perforation but lacks free air and resolves on bowel rest. The unifying frame is that the recognition cue tells you the mechanism and the mechanism tells you the response, so hematochezia, free air, focal peritonitis without free air, and left shoulder pain are not interchangeable.

    Read the transcript →
  5. 05

    Serrated Pathway, Lynch, and Special Populations

    Episode five closes the chapter on the other half of why colonoscopy quality matters, the serrated pathway where missed right-sided lesions become interval cancer. Sessile serrated lesions run through BRAF V600E, CIMP-high hypermethylation, MLH1 silencing, and microsatellite instability, which is why sessile serrated lesion detection rate is its own quality metric. That molecular route drives the Lynch reflex tree: mismatch repair immunohistochemistry, then BRAF and MLH1 methylation to triage sporadic disease, with the other loss patterns going straight to germline testing because sporadic biology cannot explain them. The special populations then bend the standard algorithm one mechanism at a time, as the kidneys forbid phosphate, the liver forbids morphine, the fetus forbids first-trimester benzodiazepines, and the IBD colon demands chromoendoscopy.

    Read the transcript →

Key topics

  • Colorectal cancer screening rationale
  • USPSTF age forty-five and the upper bound
  • High-risk starting ages and intervals
  • The screening modality menu
  • Split-dose bowel preparation physiology
  • Boston Bowel Preparation Scale adequacy
  • Cecal intubation rate and withdrawal time
  • Adenoma detection rate
  • Sessile serrated lesion detection and technology
  • Horizontal versus vertical polyp growth
  • Paris morphology classification
  • NICE and JNET optical prediction
  • Kudo pit pattern
  • Lateral spreading lesion granularity types
  • Cold snare and hot snare selection
  • Endoscopic mucosal resection and the non-lifting sign
  • Underwater EMR and margin ablation
  • ESD and Japanese curative criteria
  • Muscularis mucosae and metastatic potential
  • Intramucosal adenocarcinoma versus true cancer
  • Kikuchi and Haggitt depth systems
  • Aggregating high-risk histologic features
  • Tumor budding by ITBCC criteria
  • USMSTF twenty twenty surveillance intervals
  • Serrated surveillance intervals
  • Piecemeal EMR site surveillance
  • Immediate versus delayed post-polypectomy bleeding
  • Endoscopic hemostasis modalities
  • The prophylactic-clip decision
  • Perforation rates and recognition

Sources

Guidelines, consensus statements, and validated instruments this chapter draws on. Named here because the chapter applies them directly.

Professional society guidelines

  • American Society for Gastrointestinal Endoscopy (ASGE)

Classification and diagnostic criteria

  • Paris classification (lesion morphology)